Bacteria Engineered to Glycosylate Full-Length IgG: A Breakthrough in Antibody Production
A newly discovered single-subunit enzyme enables E. coli to glycosylate full-length IgG antibodies, paving the way for cost-effective biopharmaceutical production.
